Prolonged thrombocytopenia after CAR T-cell therapy: the role of thrombopoietin receptor agonists

0 avis

Prolonged thrombocytopenia after CAR T-cell therapy: the role of thrombopoietin receptor agonists

Archive ouverte

Drillet, Gaëlle | Lhomme, Faustine | de Guibert, Sophie | Manson, Guillaume | Houot, Roch

Edité par CCSD ; The American Society of Hematology -

International audience. No abstract available

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Impact of diagnostic investigations in the management of CAR T-cell-associated neurotoxicity

Archive ouverte | Mauget, Matteo | CCSD

International audience. International guidelines regarding the management of immune effector cell-associated neurotoxicity syndrome (ICANS) recommend several diagnostic investigations, including magnetic resonance i...

Remote Monitoring of CAR T-Cell Treated Patients by a Specialized Nurse to Detect and Manage Late Complications: Report of the CARAMA Program

Archive ouverte | Colin, Fanny | CCSD

International audience

Remission after CAR T‐cell therapy: Do lymphoma patients recover a normal life?

Archive ouverte | Perthus, Alya | CCSD

International audience. Chimeric antigen receptor T cells (CAR T cells) can induce prolonged remission in a substantial subset of patients with relapse/refractory lymphoma. However, little is known about patients�...

Chargement des enrichissements...